CSB
CRSP icon

City State Bank’s CRISPR Therapeutics CRSP Stock Holding History

City State Bank’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$476 Hold
10
– – ﹤0.01% 752
2025
Q4 		$524 Hold
10
– – ﹤0.01% 730
2025
Q3 		$648 Hold
10
– – ﹤0.01% 706
2025
Q2 		$486 Hold
10
– – ﹤0.01% 714
2025
Q1 		$340 Hold
10
– – ﹤0.01% 721
2024
Q4 		$394 Hold
10
– – ﹤0.01% 692
2024
Q3 		$470 Hold
10
– – ﹤0.01% 699
2024
Q2 		$540 Hold
10
– – ﹤0.01% 688
2024
Q1 		$1K Hold
10
– – ﹤0.01% 677
2023
Q4 		$1K Buy
+10
New +$553 ﹤0.01% 645
2023
Q3 		– Sell
-10
Closed -$1K – 693
2023
Q2 		$1K Buy
+10
New +$567 ﹤0.01% 667
2022
Q4 		– Sell
-10
Closed -$1K – 666
2022
Q3 		$1K Hold
10
– – ﹤0.01% 631
2022
Q2 		$1K Hold
10
– – ﹤0.01% 634
2022
Q1 		$1K Buy
+10
New +$628 ﹤0.01% 652

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GP
GSK plc London $599M AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return